Alici, S. Et Al. 2003. Oral etoposide (VP16) in platinum-resistant epithelial ovarian cancer (EOC).. American journal of clinical oncology , vol.26, no.4 , 358-62.

Alici, S., Saip, P., Eralp, Y., Aydiner, A., & Topuz, E., (2003). Oral etoposide (VP16) in platinum-resistant epithelial ovarian cancer (EOC).. American journal of clinical oncology , vol.26, no.4, 358-62.

Alici, Süleyman Et Al. "Oral etoposide (VP16) in platinum-resistant epithelial ovarian cancer (EOC).," American journal of clinical oncology , vol.26, no.4, 358-62, 2003

Alici, Süleyman Et Al. "Oral etoposide (VP16) in platinum-resistant epithelial ovarian cancer (EOC).." American journal of clinical oncology , vol.26, no.4, pp.358-62, 2003

Alici, S. Et Al. (2003) . "Oral etoposide (VP16) in platinum-resistant epithelial ovarian cancer (EOC).." American journal of clinical oncology , vol.26, no.4, pp.358-62.

@article{article, author={Süleyman Alici Et Al. }, title={Oral etoposide (VP16) in platinum-resistant epithelial ovarian cancer (EOC).}, journal={American journal of clinical oncology}, year=2003, pages={358-62} }